risedronic acid has been researched along with Chronic Kidney Disease-Mineral and Bone Disorder in 1 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Chronic Kidney Disease-Mineral and Bone Disorder: Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishida, H | 1 |
| Komaba, H | 1 |
| Hamano, N | 1 |
| Yamato, H | 1 |
| Sawada, K | 1 |
| Wada, T | 1 |
| Nakamura, M | 1 |
| Fukagawa, M | 1 |
1 other study available for risedronic acid and Chronic Kidney Disease-Mineral and Bone Disorder
| Article | Year |
|---|---|
Skeletal and mineral metabolic effects of risedronate in a rat model of high-turnover renal osteodystrophy.
Topics: Animals; Biomechanical Phenomena; Blood Urea Nitrogen; Bone and Bones; Bone Remodeling; Calcium; Chr | 2020 |